[HTML] springer.comFull View

[HTML][HTML] Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van Den Hof, F Cobelens, Y Zhou… - BMC Infectious …, 2020 - Springer
Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …
被引用次数：10 相关文章

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.

H Xia, S van den Hof, F Cobelens, Y Zhou… - BMC Infectious …, 2020 - europepmc.org
BACKGROUND: Pyrazinamide still may be a useful drug for treatment of rifampin-resistant
(RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of …

[引用][C] Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.

H Xia, S van den Hof, F Cobelens, Y Zhou, B Zhao… - 2020 - rivm.openrepository.com
Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant
Mycobacterium tuberculosis in China. Toggle navigation Login Toggle navigation View Item …

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.

H Xia, S van den Hof, F Cobelens, Y Zhou… - BMC Infectious …, 2020 - go.gale.com
Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …
[HTML] nih.gov

[HTML][HTML] Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van den Hof, F Cobelens, Y Zhou… - BMC Infectious …, 2020 - ncbi.nlm.nih.gov
Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …
[HTML] biomedcentral.com

[HTML][HTML] Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van den Hof, F Cobelens… - BMC Infectious …, 2020 - bmcinfectdis.biomedcentral.com
Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or
multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs …

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.

H Xia, S van Den Hof, F Cobelens, Y Zhou, B Zhao… - 2020 - cabidigitallibrary.org
Background: Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrugresistant tuberculosis (MDR-TB) in China while awaiting scale up of new …

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van den Hof… - BMC …, 2020 - researchinformation.amsterdamumc …
Background: Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van den Hof, F Cobelens… - BMC infectious …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

H Xia, S van den Hof, F Cobelens… - BMC Infectious …, 2020 - search.proquest.com
Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-
TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new …